United MedCare Capital
United MedCare Capital identifies itself as a healthcare merger-and-acquisition advisory firm. Its stated services include seller representation, buyer-side acquisition assistance, deal sourcing, valuation, exit planning, and transaction coordination.
What stands out about United MedCare Capital
United MedCare Capital focuses on healthcare businesses and publicly identifies home health, hospice, behavioral health, DME/HME, healthcare technology including SaaS, and healthcare staffing among its areas of buyer relationships. Its published opportunities page also lists home care, private-duty care, IDD/DIDD services, and hospice examples.[1][2][3][4][5][7][8]
What does United MedCare Capital do?
United MedCare Capital identifies itself as a healthcare merger-and-acquisition advisory firm. Its public service offering covers seller representation, buyer-side acquisition assistance, exit planning, valuation, and transaction coordination.[1][2][3][4][5]
Seller services include market-value assessment, presentation of qualified buyers, sales-process coordination, and negotiation support. The firm also provides buyer-side acquisition assistance and deal sourcing, including assistance with presenting, negotiating, and completing acquisition contracts.
Its exit-planning service is intended to prepare healthcare businesses for a future sale, while its valuation service is designed to establish a baseline view of a healthcare company’s worth and identify actions to increase value before a sale.[2][3][4][5]
Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.
Published criteria: The opportunities page presents deal-specific examples described at $7.5M, $5.4M, $4M, $3M, $2.2M, and $1.2M, among other listings. That page does not state a universal minimum or maximum client-size criterion.[7]
What should a business owner evaluate before hiring United MedCare Capital?
An owner evaluating United MedCare Capital can clarify how the proposed engagement would address valuation, exit planning, qualified-buyer presentation, and transaction coordination. The public examples span home health, home care, hospice, private-duty care, and IDD/DIDD businesses. The seller-services page does not establish the firm’s fee terms; the opportunities page does not establish buyer identities, closing dates, transaction values, or consideration terms; and the contact page does not establish the firm’s legal-entity form or firm-level regulatory registration status. Those items should be verified directly as part of engagement diligence.[2][4][5][7][8]
What legal entity will sign the engagement, and what firm-level registrations, licenses, or professional affiliations apply
What are the engagement fees, success-fee percentage, expense terms, exclusivity period, tail provisions, and termination rights
Which recent transactions can be verified directly with client permission, including buyer, closing date, and consideration structure
What size transactions and clients does United MedCare Capital focus on?
United MedCare Capital publicly identifies home health, hospice, behavioral health, DME/HME, healthcare technology including SaaS, and healthcare staffing among the healthcare arenas in which it has buyer relationships. Its published opportunity listings also include home care, private-duty care, IDD/DIDD services, and hospice businesses.[6][7]
The official opportunities page labels a Maryland $1.2M Home Health and Private Duty Agency as SOLD. It also labels a North Carolina Private Pay Home Care Agency as SOLD and reports 2024 gross revenues of $797,228 and Seller Discretionary Earnings of $186,208.
A Texas Hospice Agency is also labeled SOLD and described as Medicare- and Medicaid-certified and CHAP-accredited.[7]
The stated seller process begins with market-value assessment and includes presenting qualified buyers, coordinating the sales process, and supporting negotiations. On the buyer side, the firm offers acquisition assistance and deal sourcing.[2][3][5]
What does United MedCare Capital publicly disclose about fees, process and engagement terms?
The seller-services page does not publish a standard fee schedule, success-fee percentage, expense schedule, exclusivity period, tail period, or termination terms.
The opportunities page does not disclose buyer identities, closing dates, transaction values, or consideration terms for the sold listings identified there. It presents deal-specific revenue and earnings examples but does not state a universal minimum or maximum client-size criterion.
The contact page publishes an operating address and telephone number but does not state the firm’s legal-entity form or firm-level regulatory registration status.[2][7][8]
The firm identifies itself as an M&A advisory firm. Its contact page lists United MedCare Capital at 12600 Deerfield Parkway, Atlanta, GA 30004, with telephone number 800.581.5290.
The contact page does not state the firm’s legal-entity form or firm-level regulatory registration status.[1][8]
Publicly described seller services cover market-value assessment, qualified-buyer presentation, sales-process coordination, and negotiation support. Valuation services are described as establishing a baseline view of company worth and identifying actions to increase value before a sale.[2][5]
Questions to ask before hiring United MedCare Capital
What legal entity will sign the engagement, and what firm-level registrations, licenses, or professional affiliations apply?
What are the engagement fees, success-fee percentage, expense terms, exclusivity period, tail provisions, and termination rights?
Which recent transactions can be verified directly with client permission, including buyer, closing date, and consideration structure?
How many qualified buyers are currently active for the owner's specific healthcare subsector and geography?
What valuation methodology and quality-of-earnings adjustments will be used?
Sources & research notes
- Official website / firm overview
- Services / capabilities
- Services / capabilities
- Services / capabilities
- Services / capabilities
- Industry / market focus
- Geography / market coverage
- Structure / regulatory context
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.